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Introduction
Functional biological tissue-substitutes can potentially 
serve as a replacement to help regenerate damaged or 
defective tissues.1,2 Initial attempts to generate tissue-engi-
neered cartilage (TEC) involved the usage of adult autolo-
gous chondrocyte as these cells can be isolated from the 
less weight-bearing areas of the joint, amplified in vitro, 
seeded, and cultured on a scaffold in a bioreactor to form 
cartilage that can be implanted without compromising the 
patient’s immune system.1 In the last 10 years, the use of 
stem cells, which can potentially differentiate into chon-
drocytes under appropriate conditions, has been explored 
as a promising alternative.3 It is widely accepted that 
human mesenchymal stem cells (hMSCs) provide a better 
starting cell source than adult human chondrocytes for a 
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Abstract
Ultrasound at 5.0 MHz was noted to be chondro-inductive, with improved SOX-9 gene and COL2A1 protein expression 
in constructs that allowed for cell-to-cell contact. To achieve tissue-engineered cartilage using macroporous scaffolds, 
it is hypothesized that a combination of ultrasound at 5.0 MHz and transforming growth factor-β3 induces human 
mesenchymal stem cell differentiation to chondrocytes. Expression of miR-145 was used as a metric to qualitatively 
assess the efficacy of human mesenchymal stem cell conversion. Our results suggest that in group 1 (no transforming 
growth factor-β3, no ultrasound), as anticipated, human mesenchymal stem cells were not efficiently differentiated 
into chondrocytes, judging by the lack of decrease in the level of miR-145 expression. Human mesenchymal stem cells 
differentiated into chondrocytes in group 2 (transforming growth factor-β3, no ultrasound) and group 3 (transforming 
growth factor-β3, ultrasound) with group 3 having a 2-fold lower miR-145 when compared to group 2 at day 7, indicating 
a higher conversion to chondrocytes. Transforming growth factor-β3–induced chondrogenesis with and without 
ultrasound stimulation for 14 days in the ultrasound-assisted bioreactor was compared and followed by additional culture 
in the absence of growth factors. The combination of growth factor and ultrasound stimulation (group 3) resulted in 
enhanced COL2A1, SOX-9, and ACAN protein expression when compared to growth factor alone (group 2). No 
COL10A1 protein expression was noted. Enhanced cell proliferation and glycosaminoglycan deposition was noted with 
the combination of growth factor and ultrasound stimulation. These results suggest that ultrasound at 5.0 MHz could be 
used to induce chondrogenic differentiation of mesenchymal stem cells for cartilage tissue engineering.
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variety of reasons.3–5 The ability to acquire hMSCs autolo-
gously and their potential for multilineage differentiation 
and proliferative potential in vitro make hMSCs an attrac-
tive source of cells for tissue engineering.4,5 Various stud-
ies have reported on the feasibility of using hMSCs to 
form cartilage-like tissue.6–11
Chondro-induction of mesenchymal stem cell (MSC) is 
influenced by many factors, including transforming growth 
factor beta (TGFβ), ascorbic acid, as well as external 
mechanical stimuli such as three-dimensional (3D) culture 
in scaffolds, hydrostatic pressure, dynamic compression, 
and ultrasound (US).12–14 Typically, hMSCs on scaffolds or 
hydrogels are directed toward a chondrocytic lineage in 
vitro using chondrogenic medium along with a combina-
tion of physical stimuli and then are released, re-passaged, 
and re-seeded onto scaffolds and further cultured to obtain 
TEC.15,16 In an attempt to merge the two steps, recently, 
hMSCs seeded onto focal-defect-sized PLGA scaffold 
were chondro-induced for 8 weeks in a chondrogenic 
medium and then either implanted directly (one-step) or 
released, passaged, and seeded onto PLGA scaffolds and 
implanted (two-step).17 Our long-term goal is to first pro-
mote the chondrogenic differentiation of hMSCs in vitro 
using US, 3D scaffolds and growth factors and then seam-
lessly transition to expand and culture hMSC-derived 
chondrocytes on 3D scaffolds using US in a US-assisted 
bioreactor. We hypothesize that the US bioreactor creates a 
microenvironment in the seeded scaffold that assists the 
differentiation of hMSCs into chondrocytes and aids the 
maintenance of the hMSC-derived chondrocytes along 
with a uniform cellular distribution throughout the scaf-
fold volume.
A bioreactor configuration that uses US to stimulate in 
vitro cultures over a range of US stimulations has been 
designed and developed at the University of Nebraska–
Lincoln.18,19 Aspects of US that would negatively affect 
cells, including temperature and cavitation, were shown to 
be insignificant for the US protocols used covering a wide 
range of frequencies and pressure amplitudes, including 
the ones used in this study.18 We conclude that any US 
effects in the bioreactor, aside from cellular responses, are 
negligible. Furthermore, we have shown that the response 
of cells to US is frequency dependent, with a primary reso-
nant frequency at 5.0 MHz where the cells mostly undergo 
dilatation.20
The success of any bioreactor that seeks to attain line-
age-dependent conversion of hMSCs to chondrocytes 
depends upon the ability of the bioreactor to mediate the 
conversion to chondrocytic lineage by enhancing specific 
cellular pathways that control the cell-specific differentia-
tion markers. For example, in the generation of hMSC-
derived chondrocytes, bioreactors have to provide the 
mechanical conditioning to cells and enable the coupling 
of the external stimuli to nuclear process that controls 
chondrocytes’ fate via SOX-9-dependent processes.21 We 
have recently established that exposure of adult chondro-
cytes to US at 5.0 MHz significantly modulates the level of 
gene expression of a variety of chondrocyte-specific genes 
(i.e. SOX-9) and that this likely occurs through signals 
transmitted to chondrocytes.22,23
Current protocols use ≤10 ng/mL of TGFβ (1 or 3) in 
the chondrogenic differentiation medium.6,24 Further 
inductive molecules (i.e. TGFβ3 alone) when acting alone 
may have limited capacity to direct specific differentiation 
pathways, and we further hypothesize that the synergism 
between US-mediated cell processes and signaling pro-
vided by TGFβ may augment the cell fate processes.
We hypothesize that by combining continuous, low-
intensity US with 3D culture techniques and growth fac-
tors, we can engineer an optimized microenvironment to 
induce MSC differentiation to chondrocytes, and the 
microenvironment can promote the MSC-derived chon-
drocytes to thrive and produce cartilage-specific markers. 
Thus, in this study, we seeded hMSCs on macroporous 
scaffolds, cultured hMSC-seeded constructs in the pres-
ence of TGFβ3 for 14 days in the US-assisted bioreactor, 
and continued the culture in the US-assisted bioreactor for 
an additional 7 days in the absence of any exogenously 
added growth factors. During culture, cell-seeded scaf-
folds were retrieved from respective groups and chondro-
genic differentiation of hMSCs was assessed as follows: 
proliferation by Picogreen™ assay, total collagen content 
by hydroxyproline assay, total glycosaminoglycan (GAG) 
by dimethylmethylene blue (DMMB) assay, microRNA 
(miRNA) and messenger RNA (mRNA) expression by 
quantitative real-time polymerase chain reaction (qRT-
PCR), and protein expression by western blotting, histol-
ogy, and immunohistochemistry.
Materials and methods
Polyurethane-urea-based macroporous 3D scaffolds 
(denoted as BM) were received as generous gift from 
Biomerix Corporation, Somerset, NJ, USA. Unless other-
wise stated, all chemicals were ACS grade and purchased 
from Sigma (St. Louis, MO, USA).
hMSC culture and generation of cell-seeded 
constructs
Bone marrow–derived hMSCs were obtained from Lonza 
(Walkersville, MD, USA) and expanded in medium-1 (M1) 
consisting of alpha-Minimum Essential Medium (MEM) 
supplemented with 10% mesenchymal stem cells qualified 
fetal bovine serum (FBS), 1X Glutamax™, and 1X antibi-
otic–antimyotic™ solution. Passage 5 hMSCs were used in 
all experiments. hMSC pellet cultures (~3 × 105 
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Alameda, CA, USA) using instructions provided by the 
manufacturer.26–28 Typically, ~105 cells/mL were encapsu-
lated in Hystem-C matrices and were transferred to ultra-
low attachment 6-well plates.
To obtain prewetted scaffolds, BM scaffolds 
(5 mm × 2.5 mm) were sterilized with sequential treat-
ments of 70% ethanol for 1 h followed by sterile 1X phos-
phate buffered saline (PBS) rinse and then incubated for 
12 h in medium (high-glucose Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% FBS). One 
side of the prewetted scaffold disks was seeded with 
hMSCs (passage 5) at a seeding density of 2 × 105 cells/
scaffold using procedures outlined elsewhere29 and were 
transferred to a new six-well tissue culture plate (TCP) 
housing a cell crown™ insert/well with 15–18 scaffolds/
insert.
Medium 2 (denoted as M2) containing high-glucose 
DMEM, 10% FBS, 100 nM dexamethasone, 50 µg/mL of 
L-ascorbic Acid, and 1X antibiotic–antimyotic solution was 
further supplemented with TGFβ3 according to Figure 1  
for chondrogenic differentiation and denoted as chondro-
genic differentiation media (CDM; M2 + TGFβ3). After 
14 days of culture, M2 or CDM was removed and cell- 
constructs were cultured for an additional 1 week in Medium 
3 (M3) comprising M2 without dexamethasone (Table 1). 
All supplements and media for cell culture were purchased 
from Life Technologies (Grand Island, NY, USA).
Experimental methods followed in US-assisted 
bioreactor
hMSC-seeded scaffolds were either cultured in CDM 
(group 2) or in combination of CDM and US stimulation 
(group 3) for 21 days according to Table 1. hMSC-seeded 
scaffolds cultured in M2 and no US stimulation (group 1) 
served as control (Table 1). Six-well TCPs containing 
MSC pellets, MSCs in Glycosan™ matrices, and MSC-
seeded scaffolds (group 3 only) were placed in plate holder 
of the US-assisted bioreactor developed at the Department 
of Chemical and Biomolecular Engineering, University of 
Nebraska–Lincoln, Lincoln, NE, USA.18 The experimental 
setting was described elsewhere.29 Automated US stimula-
tion was provided in the near field at the following regi-
men: 14 kPa (5.0 MHz, 2.5 Vpp), 5 min/application and 6 
applications/day at a regular interval. At indicated time 
points, cell-seeded scaffolds were retrieved randomly from 
respective groups and assayed as indicated.
Cell viability
Cell-seeded scaffolds were treated with LIVE/DEAD® 
Viability/Cytotoxicity Kit (Life Technologies) according 
to previously published protocol19 and visualized with 
inverted Confocal Microscope (Olympus IX 81) at the 
Center of Biotechnology, University of Nebraska–Lincoln. 
Figure 1. TGFβ3 dose in CDM over 1–21 days. hMSCs were seeded on Biomerix™ scaffolds (2 × 105 cells/scaffold, 5 mm × 2.5 mm) 
and cultured in the US-assisted bioreactor. The following independent study groups (Table 1) were adopted: Group 1—No TGFβ3, 
No US (Control); Group 2—TGFβ3, No US; and Group 3—TGFβ3, US. TGFβ3 concentrations used are indicated above. After 
14 days of culture in M2 or CDM, cell-constructs were cultured for an additional week in M3.
Table 1. Construct culture condition.
Study groups Media usage over 21 days US regimen over 21 days
 1–14 days 15–21 days  
Group 1 M2a M3b –
Group 2 CDMc M3b –
Group 3 CDMc M3b 14 kPa 5 min/application, 6X/day
US: ultrasound; CDM: chondrogenic differentiation media; FBS: fetal bovine serum; DMEM: Dulbecco’s Modified Eagle Medium; TGFβ3: transforming 
growth factor-β3.
aM2: high-glucose DMEM, 10% FBS, 100 nM dexamethasone, 50 
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All the images were collected at 20× magnification (z step 
size = 10 µm).
Biochemical analysis
Randomly selected scaffolds (n = 5–8) per study group 
were first washed with sterile 1X PBS and incubated with 
papain digestion buffer (5 mM L-cysteine, 100 mM 
Na2HPO4, 5 mM EDTA, 125 µg/mL papain, pH = 7.5) for 
16–18 h at 70°C. Upon completion of the incubation, scaf-
folds were spun down, and supernatants were collected 
and subjected to DNA, GAG, and Hydroxyproline content 
measurements.30 Double-stranded DNA (dsDNA) was 
measured using Quant-iT™ PicoGreen® dsDNA Assay Kit 
(Life Technologies) according to manufacturer’s instruc-
tions. All quantifications were based on a λ DNA standard. 
Total GAG content was determined with DMMB assay on 
papain-digested supernatant according to the protocol 
described elsewhere31 and quantified based on shark chon-
droitin sulfate standard. Hydroxyproline content was 
measured on the papain-digested supernatant accordingly 
using Hydroxyproline Assay Kit (Sigma) according to 
manufacturer’s instructions. Deionized (DI) water was 
used as a blank in the assay measurements. Total collagen 
was extrapolated from hydroxyproline content as hydroxy-
proline amino acid comprises 13.5% of total collagen.32
Cell release from BM scaffolds and isolation of 
small and large RNA fractions
After desired treatment, cell-seeded scaffolds were 
retrieved immediately, rinsed with ice-cold HBSS, and 
finally, cells were released by incubating with 1X trypsin. 
Followed by scaffold removal, trypsin was neutralized 
with 10% FBS supplemented media, and the cell suspen-
sion was centrifuged at 1000×g for 10 min to obtain the 
cell pellet. Cell pellet obtained after releasing cells from 
scaffolds was treated to isolate small and large RNA frac-
tion using the miRNA isolation kit (Life Technologies) as 
per manufacturer’s instructions. The small RNA fraction 
contained RNAs with size less than 200 nucleotides and 
used for miRNA gene expression analysis, whereas large 
RNA fraction was used for mRNA gene expression 
analysis.
miRNA reverse transcription and qRT-PCR 
analysis
The miRNA level was quantified using TaqMan-based 
qRT-PCR. All reagents and primers (detailed in Table 2) 
were purchased from Applied Biosystems (Foster City, 
CA, USA). The qRT-PCR analysis was carried out using 
two-step method. In step 1, reverse transcription reaction 
was performed; 20 ng of each small RNA fraction sample 
was mixed with MultiScribe reverse transcriptase, RNase 
inhibitor, and nuclease-free water as per manufacturer’s 
instruction, and mixtures were incubated for 30 min at 
16°C, 30 min at 42°C, and then 5 min at 85°C. In step 2, 
qRT-PCR was carried out using Eppendorf’s thermocycler 
RealPlex real-time PCR system (Eppendorf North 
America, Hauppauge, NY, USA). The PCR master mix 
containing TaqMan 2X Universal PCR Master Mix (No 
AmpErase UNG), 10X TaqMan assay, and RT products in 
20 µL volume was processed as follows: 95°C for 10 min 
and then 40 cycles of 95°C for 15 s and 60°C for 60 s 
(n = 3). The amplified expression of miR-145 transcript 
was normalized to SnU6 expression; 2−ΔΔCt method was 
used to calculate relative expression levels.
mRNA gene expression analysis
Large RNA fraction was collected as described above and 
quantified by qRT-PCR using QuantiFast Probe RT-PCR 
Kit (Qiagen, Valencia, CA, USA); 50 ng of total RNA was 
added per 10 µL reaction vial with RT mix, RT-PCR master 
mix, sequence-specific primers, and TaqMan probes. 
Sequences of primers (Table 2) are proprietary to Applied 
Biosystems and not disclosed. qRT-PCR assays were car-
ried out in triplicate on Eppendorf’s Mastercycler® 
RealPlex real-time PCR system (Eppendorf North 
America). Cycling was initiated by 10 min for comple-
mentary DNA (cDNA) formation by reverse transcriptase 
enzyme at 50°C and 5 min polymerase activation at 95°C, 
followed by 40 cycles at 95°C for 30 s, at 55°C for 30 s, 
Table 2. List of primers.
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and at 72°C for 1 min. The threshold was set above the 
non-template control background and within the linear 
phase of target gene amplification to calculate the cycle 
number at which the transcript was detected. The ampli-
fied expression of mRNA transcripts was normalized to 
GAPDH expression; 2−ΔΔCt method was used to calculate 
relative expression levels.
Protein isolation and western blotting analysis
At the end of 14 days of culture, cells were released from 
scaffolds with 1X Trypsin followed by pelleting cells at 
1000×g and finally lysing the pellet with Pierce IP lysis 
buffer supplemented with 1X Halt protease and phos-
phatase inhibitor cocktail (Thermo Scientific, Rockford, 
IL, USA). After centrifugation of the lysate at 15,000×g 
for 10 min at 4°C, supernatants were collected and the pro-
tein concentration was measured by the bicinchoninic acid 
(BCA) method. A volume equivalent to a total protein of 
8 µg (for COL1A1, COL2A1, COL9A1, ACAN protein 
expression) and 16 µg (for COL10A1, SOX-9, p-SOX-9 
protein expression) of all samples were subjected to SDS-
PAGE analysis on a 10% NuPAGE Bis-tris gel (Life 
Technologies), followed by western blotting to PVDF 
using the NuPAGE system. After the transfer, the mem-
branes were blocked with 0.5% casein in 1X TBST 
and probed separately with COL1A1 (Santa Cruz 
Biotechnology CA, USA; 80565), COL2A1 (ABCAM; 
ab34712), COL9A1 (Santa Cruz Biotechnology; 376969), 
COL10A1 (ABCAM; ab182563), SOX-9 (Millipore- 
ab5535), phospho S181-SOX-9 or p-SOX-9 (ABCAM; 
ab59252), and Aggrecan (ABCAM; ab3773). β-Actin was 
used as the respective loading control. After washing the 
membranes with 1X TBST and incubating with respective 
horseradish peroxidase (HRP)–linked secondary antibod-
ies incubation procedures, protein bands were visualized 
using an Immun-star HRP substrate kit (Bio-Rad 
Laboratories, Hercules, CA, USA) and captured with GE 
Healthcare Amersham Hyperfilm ECL (GE Healthcare, 
Piscataway, NJ, USA).
Histology and immunohistochemistry
Cell-seeded constructs were rinsed with 1X PBS, fixed in 
4% formalin for 24 h, and embedded in paraffin. Histological 
sections of 15 µm thickness were prepared from selected 
construct using standard histological procedures with Leica 
Bond III at the Tissue Science Facility, University of 
Nebraska Medical Center (Omaha, NE, USA). Sections 
were separately stained with hematoxylin and eosin (H&E), 
Alcian Blue (AB), and Masson Trichrome (MTC) and also 
subjected to immunohistochemical staining using antibod-
ies specific to COL1A1 (ab138492; ABCAM, MA) and 
COL2A1 (ab34712; ABCAM, MA). Bond DAB enhancer 
reaction was performed using the Bond polymer refine 
detection kit (Leica Biosystems, Richmond, IL, USA) to 
visualize protein expression on the respective scaffolds.
Statistical analysis
All results were expressed as a mean with standard devia-
tions (SDs). Sample sizes (n) specific to individual analysis 
were indicated in the associated methods and figure legends. 
One-way analysis of variance (ANOVA) with replication 
was used to compare all study groups/scaffold type. A pair-
wise Student’s t-test with unequal variance was used to 
observe significant changes among either stimulated or non-
stimulated scaffold type at each sampling day. Difference 
was considered significant when p < 0.05 (denoted as *), 
p < 0.01 (denoted as **), and p < 0.001 (denoted as ***).
Results and discussion
Lineage-dependent conversion of MSCs into chondro-
cytes, in vitro, is impacted by a multitude of factors and 
stands as a special culture system that seeks to mimic the 
critical steps of limb bud chondrogenesis.33 Culture condi-
tions, growth factors, scaffold microstructure, and stiffness 
and mechanical microenvironment have all shown to 
impact the chondrogenesis of hMSCs.13,14,24 Previous 
reports have shown that certain distinct cell-specific tran-
scription factors (i.e. master genes) control cell lineage 
commitment of MSCs into chondrocytes, and SOX-9 has 
been identified as the only transcriptional factor that con-
trols COL2A1 expression.34 SOX-9 has been shown to 
play a pivotal role in the commitment of MSCs to a chon-
drogenic cell lineage, and in cooperation with SOX-5 and 
SOX-6, it regulates chondrocyte proliferation, maturation, 
and matrix production.21,34
US has been previously employed to promote chondro-
genesis of hMSCs.35–37 However, previous studies involv-
ing US have used low-intensity pulsed US (1.5 MHz, 
1.0 kHz repeat, 6–40 min) to stimulate in vitro MSC cul-
tures.35,36,38–40 As a significant departure from such strate-
gies, we have employed low-intensity continuous US of 
5.0 MHz to stimulate hMSCs seeded in 3D matrices. What 
also sets us apart is the fact that we are stimulating the 
chondrocytes at 5.0 MHz, the primary resonant frequency 
at which the cytoplasmic and nuclear stress is maximized 
and resulting in enhanced mechanotransduction.19,23 
Previously, we have modeled mammalian cell dynamics in 
response to US, and a primary resonant frequency of 
5.2 ± 0.8 
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is used in this article.29,41 We have also recently established 
via modeling and experimentation that the open pore 
architecture and pore size of BM scaffolds permit an even 
distribution of US field within the scaffold volume and 
minimize attenuation, thus allowing for the maximum cou-
pling of mechanical energy to the cells.29
In an attempt to isolate the impact of US-induced MSC 
chondrogenesis from growth factors and to ascertain the 
chondro-inductive ability of US at 5.0 MHz, MSC media 
(M2, no exogenous growth factors) was used to culture 
hMSC pellets, MSCs encapsulated in Glycosan, and MSCs 
seeded on macroporous BM scaffolds in these initial sets 
of experiments. The SOX-9 gene expression was assessed 
and shown in Figure 2. In comparison to controls (day-0), 
MSC pellets had a 7-fold higher expression of SOX-9 and 
MSC pellets exposed to US stimulation had an 11-fold 
higher expression of SOX-9. MSC-Glycosan exposed to 
US stimulation had 2.4-fold higher gene expression of 
SOX-9 when compared to unstimulated MSCs encapsu-
lated in Glycosan, where MSC-Glycosan had a 13-fold 
higher expression compared to day-0 control. SOX-9 gene 
expression levels were similar between day-0 controls and 
unstimulated cell-seeded BM constructs; however, an 
11-fold higher gene expression of SOX-9 was noted on 
US-stimulated cell-seeded BM constructs. Inserts show 
the protein expression of COL2A1 by western blotting in 
MSCs encapsulated in Glycosan and MSCs seeded in BM 
constructs. The successful differentiation of MSCs to 
chondrocytes in pellet cultures in the presence of TGFβ3 
(10 ng/mL) is also demonstrated. Irrespective of the cellu-
lar microenvironment, Figure 2 shows that SOX-9 (a type-
II collagen transcription factor) expression was enhanced 
by US, in the absence of exogenously added growth fac-
tors. The ability of US to impact hMSC proliferation in the 
absence of TGFβ3 was also evaluated and depicted in 
Figure 3(a). Our results indicate that US impacts hMSC 
proliferation in the absence of exogenously added growth 
factors. Although the standard method of pellet culture for 
in vitro MSC chondrogenesis is effective and mimics the 
MSC condensation phase in the limb bud (i.e. high density 
and cell-to-cell contact), the requirement for pellet culture 
makes scale-up problematic in addition to the limitations 
in pellet size, diffusional limitations, and hypertrophy in 
the pellet core. As an alternative to pellet cultures, hydro-
gels have been developed as they can provide higher cell 
density upon encapsulation and mimic the initial phase of 
mesenchymal condensation. Indeed, our results with 
MSC-Glycosan show that the gene expression of SOX-9 
was comparable to pellet cultures, with additional increase 
in SOX-9 gene expression upon US stimulation.
Figure 2. SOX-9 expression is increased with culture environment and US application. MSC pellets (~5 × 105 cells/pellet, 1 mm 
diameter), MSCs encapsulated in Glycosan (Hystem-C™) hydrogel matrices (105 cell/mL), and MSCs seeded on macroporous 
Biomerix™ scaffolds (2 × 104 cells/scaffold, 5 mm × 2.5 mm) were cultured in M2 for 21 days and treated with and without US 
(5.0 MHz, 2.5 Vpp, 3 min, 4 times/day). M2: high-glucose DMEM, 10% FBS, 100 nM dexamethasone, 50 µg/mL of L-ascorbic acid, 
and 1X antibiotic–antimyotic™; CDM: M2 with TGFβ3; M3: M2 without dexamethasone. Control is mRNA collected from a MSC 
pellet at the start of the experiment, 0 days. qRT-PCR analysis for SOX-9 gene expression was performed. Inserts show the protein 
expression of COL2A1. (a) Cell pellet was stained for COL2A1 (red; chondrocytes) and PPARγ (green; adipocytes); (b) cell pellet 
was stained with Alcian Blue 8GX to demonstrate glycosaminoglycans—COL2A1 expression at 130 
Thakurta et al. 7
While encouraging findings with respect to chondro-
genic differentiation of hMSCs were noted in pellet cul-
tures and in hydrogel-based matrices, in this article, we 
focused on the chondrogenic differentiation of hMSCs on 
scaffolds where the cellular milieu is different from pellet 
cultures, as lineage-dependent conversion of hMSCs on 
scaffolds is more relevant to tissue engineering applica-
tions that aim to develop macroscopic amounts or larger 
constructs to treat full thickness defects. Previous studies 
have presented that various types of biomaterial substrates 
can promote chondrogenesis without the need for pellet 
culture or supplemented growth factors.42 It is not surpris-
ing that SOX-9 expression levels similar to control were 
noted in MSC-seeded BM constructs without US stimula-
tion, perhaps owing to poor cell-to-cell contact as it is dif-
ficult to attain higher cell densities in scaffolds (Figure 2). 
We have observed the induction of mesenchymal stem cell 
chondrogenesis under US, notably in the absence of TGFβ 
supplementation. A key question arising from our study is 
how US can induce chondrogenesis in the absence of 
TGFβ. MSCs cultured in vitro are known to express their 
own TGFβ;43,44 thus, it is possible that TGFβ secreted 
reaches fairly high concentrations in the supernatant of 
MSCs cultured in vitro and promotes signaling. However, 
higher levels of COL2A1 protein expression were noted in 
MSC-Glycosan cultures when compared to MSC-seeded 
BM scaffolds, both under US stimulation and no US stim-
ulation; expression levels between non-stimulated MSC-
Glycosan and US-stimulated MSC-seeded BM constructs 
were similar qualitatively. It may then be instructive to 
attain a higher seeding density in porous scaffolds; hence, 
in subsequent studies, we have used higher starting seed-
ing densities. These results are consistent with previous 
studies showing that when MSCs are cultured on scaffolds 
that do not promote aggregation, chondrogenesis can still 
proceed, suggesting that with the appropriate artificial 
environment, aggregate formation or inclusion of TGFβ 
may not be absolutely necessary to induce chondrogene-
sis.42 However, the levels of COL2A1 expression are lower 
on BM scaffolds, leaving room for further enhancement. 
Chondrogenic differentiation of MSCs, in vivo, is accu-
rately regulated by essential transcription factors and sign-
aling cascades.21,34 For example, during chondrogenesis in 
vivo, in limb bud mesenchyme, TGFβ signaling is impor-
tant in the initial stages, where it regulates the expression 
of SOX-9; hence, many in vitro cultures include TGFβ to 
induce chondrogenesis.34 Thus, moving forward, we have 
supplemented the media with TGFβ3 to aid MSC chondro-
genesis, in synergy with US stimulation.
Previous studies have documented the use of TGFβ1 or 
TGFβ3 to aid chondrogenesis in in vitro cultures, and 
mostly TGFβ concentrations in the ranges of 1–10 ng/mL 
were employed.24 Prolonged exposure to TGFβ in the cul-
ture medium is known to induce hypertrophy or increased 
COL10A1 expression in MSC cultures.45 We surmise that 
the presence of TGFβ is essential during the initial phase 
of hMSC chondrogenesis as compared to later stages 
when co-cultures of hMSCs and hMSC-derived chondro-
cytes might exist; hence, culture conditions as depicted in 
Figure 1 were adopted.
The proliferation and viability of hMSCs and hMSC-
derived chondrocytes were assessed and shown in Figure 3(b) 
Figure 3. (a) Enhancement of hMSC proliferation using US. MSCs were grown on glass coverslips for 4 days in M2 medium 
with and without US (14 kPa; 3 min; 1, 2, or 4 times/day). Cells were fixed and stained for Ki67 (mitosis marker) and Hoechst 
(nuclear marker). Five pictures were randomly taken on three coverslips per condition (n = 15), and Ki67 and Hoechst positive 
cells were counted using ImageJ™. Data were expressed as percent Ki67 positive. (b) hMSC proliferation is increased with US 
application. hMSC-seeded scaffolds were cultured in CDM for 14 days and in M3 media for another 7 days in the US-assisted 
bioreactor according to the culture conditions outlined in Table 2. dsDNA was assayed by Picogreen assay. Data were presented as 
average ± standard deviation (n = 5–8 constructs). Statistically significant data were accounted with respect to respective control and 
shown as *p < 0.05, **p < 0.01, and ***p < 
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and Figure 4, respectively. At day 21, Group 3 had signifi-
cantly higher cell proliferation (p < 0.01) when compared to 
groups 1 and 2. Over the culture period, enhanced cell viabil-
ity was noted in groups 2 and 3 with respect to group 1.
Chondrogenic differentiation of hMSCs seeded on BM 
scaffolds, cultured for 21 days, was assessed by means of 
total GAG and collagen content (Figure 5(a) and (b)). 
Significantly high GAG/DNA (p < 0.01) was observed in 
Figure 4. Cellular viability. hMSC-seeded constructs were cultured in CDM media for 14 days and in M3 for another 7 days in the 
US-assisted bioreactor according to culture conditions listed in Table 2. Live cells were stained with calceinAM (green color) and 
dead cells with ethidium (red color) and imaged at 20× magnification (scale bar: 50 µm).
Figure 5. Total glycosaminoglycan (GAG) and collagen (COL) assay: hMSC-seeded scaffolds were cultured for 21 days under 
mentioned conditions. Total GAG and COL (extrapolated from hydroxyproline content) content per scaffold were estimated at 
1, 7, 14, and 21 days. Relative content of (a) GAG to DNA and (b) COL to DNA of group 1, 2, and 3 constructs were plotted. 
Average with standard deviations are represented (n = 5–8 constructs) (*p < 0.05; **p < 
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Figure 6. miR-145 gene expression was quantified after 7, 14, and 21 days of culture according to culture conditions listed in 
Table 2. Gene expression was analyzed by qRT-PCR and normalized to the expression of the house keeping gene snU6. Each bar 
represents the mean ± standard deviation (n = 3; *p < 0.05, **p < 0.01).
qRT-PCR: quantitative real-time polymerase chain reaction.
Figure 7. hMSC-seeded Biomerix™ scaffolds were cultured according to culture conditions listed in Table 2. (a) COL10A1 gene 
expression was presented after 7, 14, and 21 days of culture. (b) Expression for ACAN, TGFβ1, and TGFβ3 genes was shown at day 
21. Gene expression was analyzed by qRT-PCR and normalized to the expression of the house keeping gene GAPDH. Each bar 
represents the mean ± standard deviation (n = 3; *p < 0.05; **p < 0.01).
group 3 constructs on both day 14 and 21 samples with 
respect to groups 2 and 3. Collagen/DNA was significantly 
high for group 3 on day 21 compared to groups 1 and 2.
miRNA gene regulation is often not a decisive on and 
off switch but a subtle function that fine-tunes cellular 
phenotypes.46 As miR-145 is significantly downregulated 
during MSC chondrogenesis and is silenced in differenti-
ated MSCs,46 we have used miR-145 expression to track 
the differentiation process under US and TGFβ3. Figure 6 
shows the differential expression of miRNA 145 during 
chondrogenic differentiation of hMSCs under US. Our 
results suggest that in group 1 (No TGFβ3, No US), as 
anticipated, hMSCs were not efficiently differentiated into 
chondrocytes, judging by the lack of decrease in the level 
of miR-145 expression. hMSCs differentiated into chon-
drocytes in group 2 (TGFβ3, No US) and group 3 (TGFβ3, 
US), with group 3 having a 2-fold lower miR-145 when 
compared to group 2 at day 7, indicating a higher conver-
sion to chondrocytes. Overall, a 20% higher rate of con-
version may be inferred based on a linear fit to the data.
The impact of US stimulation on the expression of 
COL10A1 gene as a function of culture duration was exam-
ined by qRT-PCR and is shown in Figure 7. On day 7, the 
gene expression of hypertrophic marker, COL10A1, was 
higher in group 2 (TGFβ3, No US) when compared to group 
3 (TGFβ3, US) and considerably greater when compared to 
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Figure 8. Analysis of protein expression. Cell-seeded scaffolds were randomly collected, trypsinized, lysed with IP lysis buffer—1X 
Halt protease and phosphatase inhibitor cocktail and cell lysates were subjected to SDS-PAGE followed by western blotting. (a) In 
separate experiments, the membranes were incubated with primary antibodies against ACAN, COL1A1, COL2A2, COL9A1, SOX-
9, p-SOX-9 (i.e. p-S181-SOX-9). β-Actin was used as the loading control. (b) All protein bands were quantified by ImageJ™ software 
and relative protein expression levels were computed with respect to β-actin.
group 1 (No TGFβ3, No US). The gene expression of 
COL10A1 in group 1 stayed relatively unchanged during the 
course of this experiment. On day 21, groups 2 and 3 had 
similar levels of COL10A1 mRNA levels and were signifi-
cantly different from mRNA levels in group 1. The relative 
gene expression of ACAN gene, a member of aggrecan/ver-
sican proteoglycan (ACAN), was also carried out. At day 
21, compared to group 1, higher levels of ACAN expression 
were observed on groups 2 and 3; with group 3 presenting 
the highest gene expression of ACAN. No significant differ-
ence was noted between the groups with respect to the gene 
expression of TGFβ1.
The survival, proliferation, and ECM production of 
MSC-derived chondrocyte in response to US was exam-
ined by allowing the experiment to progress for an addi-
tional week after the removal of TGFβ3 (i.e. CDM) and 
culturing in M3. In a separate study, we have shown that 
adult chondrocytes can be successfully cultured over scaf-
folds in the US-assisted bioreactor for 3 weeks.29 Compared 
to non-stimulated controls, US-stimulated constructs had a 
higher cell density throughout the scaffold volume, higher 
total cell proliferation, a ~13/1 ratio of COL2A1/COL1A1, 
no detectable COL10A1 gene expression, and uniform 
deposition of COL2A1 protein. Thus, we are confident 
that in a future study, we will be able to culture hMSC-
derived chondrocytes for an extended period of time and 
evaluate tissue properties.
The protein expression of ACAN, COL1A1, COL2A2, 
COL9A1, SOX-9, p-SOX-9 (i.e. p-S181-SOX-9), and 
COL10A1 were assayed by western blotting and shown 
in Figure 8. COL10A1 was undetectable. When com-
pared to groups 1 and 2, group 3 showed higher levels of 
COL2A1 and ACAN. COL1A1 expression was similar 
between all groups. Protein expression of both SOX-9 
and p-SOX-9 was slightly higher in group 3 compared to 
groups 2 and 1. Our combined gene and protein expres-
sion analyses at the end of day 14 indicate that US is able 
to mediate chondrogenesis of hMSCs seeded on BM 
scaffolds and this likely happens via SOX-9 mediated 
pathways.
Histological findings on scaffolds harvested from day 
21 show cellularity (H&E) and deposition of GAG (AB) 
and collagen (MTC), shown in Figure 9. Relative expres-
sions of COL1A1 and 2A1 detected by immunohisto-
chemistry (Figure 9) mirrored the changes detected by 
western blot. COL2A1 expression markedly increased in 
group 3 with the combination of TGFβ3 and US treatment 
compared to groups 1 and 2.
While in this article we have evaluated the gene or pro-
tein expression profiles from a mixed population of hMSCs 
and hMSCs that were converted to chondrocytes, we are 
able to partly comment of the efficacy of conversion based 
on miRNA expression. In our ongoing work, we plan to 
quantify the efficacy and uniformity of chondrogenesis by 
histological and immunohistochemical staining to ascer-
tain the total number of cells that stain positively for pro-
teoglycan/chondroitin sulfate relative to the total cell 
number (DAPI).
In summary, our results show that US stimulation at 
5.0 
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absence of exogenous TGFβ. Our study also highlights 
the importance of the scaffold microenvironment in regu-
lating the lineage-specific conversion of hMSCs. In the 
absence of growth factors, chondrogenic differentiation 
(as inferred from COL2A1 expression) on the macropo-
rous scaffolds appeared to be lower to that which occurs 
in standard pellet cultures, suggesting the use of higher 
starting seeding densities. We have also demonstrated that 
US acts synergistically with TGFβ to promote efficient 
chondrogenesis of MSCs seeded on polymeric scaffolds 
that limit cell-to-cell contact. Our future efforts will be 
focused on the further culture of hMSC-derived chondro-
cytes for longer duration, and a comprehensive evaluation 
will be carried out. Also, we will study the underlying 
molecular mechanisms that impact MSC chondrogenesis 
in hydrogel-based and macroporous polymeric scaffolds 
under US stimulation and non-stimulation. The ultimate 
goal is to connect the cellular microscopic inputs to mac-
roscopic inputs like tissue properties.
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